Quantitative COVID-19 Serology Testing to Measure Immune Response
ProterixBio offers the quantitative COVID-19 serology testing services through our high-complexity, CLIA-certified clinical testing laboratory. Our lead test measures antibodies that bind the Receptor Binding Domain (RBD) of the spike protein of the SARS-CoV-2 virus, which are associated with neutralizing activity and relevant to potential development of immunity. The test output is a numerical index related to the levels of antibodies and can be tracked over time.
Learn more about how ProterixBio’s quantitative COVID-19 serology test fits into vaccination follow up.View our COVID-19 Serology Test Menu